0001213900-24-008745.txt : 20240201 0001213900-24-008745.hdr.sgml : 20240201 20240201083319 ACCESSION NUMBER: 0001213900-24-008745 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240131 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240201 DATE AS OF CHANGE: 20240201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 24585138 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 8-K 1 ea192624-8k_enzobiochem.htm CURRENT REPORT
false 0000316253 0000316253 2024-01-31 2024-01-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): January 31, 2024

 

ENZO BIOCHEM, INC.

(Exact name of registrant as specified in its charter)

 

New York   001-09974   13-2866202
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

81 Executive Blvd. Suite 3

Farmingdale, New York 11735

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (631) 755-5500

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
Common Stock, par value $0.01 per share   ENZ   The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

  

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On January 31, 2024, the board of directors (the “Board”) of Enzo Biochem, Inc. (the “Company”) appointed Kara Cannon to serve as the Chief Executive Officer of the Company and Patricia Eckert, CPA, to serve as the Chief Financial Officer of the Company, in each case, until her successor is duly elected and qualified. Ms. Cannon previously served as the Company’s interim Chief Executive Officer since her appointment to such position on September 5, 2023, as disclosed in a Current Report on Form 8-K filed by the Company on September 7, 2023. Prior to that, Ms. Cannon was the Company’s Chief Operating Officer; she has been employed with the Company since 2011. Ms. Eckert previously served as the Company’s interim Chief Financial Officer since November 14, 2022, as disclosed in a Current Report on Form 8-K filed by the Company on October 20, 2022.

 

Each of Ms. Cannon’s and Ms. Eckert’s biographies is set forth in the Company’s definitive proxy statement for its 2023 Annual Meeting of Shareholders (which was held on January 31, 2024) (the “2023 Annual Meeting”), filed with the Securities and Exchange Commission on December 21, 2023. Neither Ms. Cannon nor Ms. Eckert has any family relationships with any of the Company’s directors or executive officers, and is not a party to, and does not have any direct or indirect material interest in, any transaction requiring disclosure under Item 404(a) of Regulation S-K.

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

At the 2023 Annual Meeting, the holders of 44,403,262 (87.94%) shares of the Company’s common stock outstanding and entitled to vote, as of the December 8, 2023 record date for the meeting, were represented in person or by proxy; accordingly, a quorum was present.

 

The shareholders of the Company voted at the 2023 Annual Meeting on the following items: (1) the election of Steven J. Pully, Bradley L. Radoff, Mary Tagliaferri, M.D., and Kara Cannon to the Board to hold office for a term ending as of the Company’s 2024 Annual Meeting of Shareholders, and until each such director’s successor is elected and qualified; (2) the approval, by a nonbinding advisory vote, of the compensation of the Company’s named executive officers; and (3) the ratification of the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2024. The voting results with respect to each of the matters described were as follows:

 

1.  The shareholders of the Company elected each of Steven J. Pully, Bradley L. Radoff, Mary Tagliaferri, M.D., and Kara Cannon to serve on the Board for a term ending as of the Company’s 2024 Annual Meeting of Shareholders, and until each such director’s successor is elected and qualified, as set forth below.

 

Name 

Votes

For

  

Votes

Against

   Withheld  

Broker

Non-Votes

 
Steven J. Pully   29,437,282    841,882    4,824,409    9,299,689 
Bradley L. Radoff   23,341,654    6,914,452    4,847,467    9,299,689 
Mary Tagliaferri, M.D.   22,450,690    7,832,236    4,820,647    9,299,689 
Kara Cannon   29,645,663    5,387,299    70,611    9,299,689 

 

1

 

 

2.  The shareholders of the Company did not approve, by a nonbinding advisory vote, the compensation of the Company’s named executive officers, as set forth below.

 

Votes For  Votes Against  Abstentions 

Broker

Non-Votes

13,934,600  17,310,884   3,858,089   9,299,689 

 

3.  The shareholders of the Company ratified the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2024, as set forth below.

 

Votes For  Votes Against   Abstentions  

Broker

Non-Votes

 
39,403,460  117,240   4,882,562    0 

 

Item 7.01 Regulation FD Disclosure

 

On February 1, 2024, the Company issued a press release announcing the results of the 2023 Annual Meeting. The full text of the press release is furnished as Exhibit 99.1 hereto and incorporated by reference herein. The information in this Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly stated by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
Number		   Description
99.1   Enzo Biochem, Inc. Press Release dated February 1, 2024
104   Cover Page Interactive Data File (formatted in Inline XBRL)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ENZO BIOCHEM, INC.
     
  By: /s/ Patricia Eckert
  Name:  Patricia Eckert
  Title: Chief Financial Officer
Date: February 1, 2024     

 

 

3

 

 EX-99.1 2 ea192624ex99-1_enzobiochem.htm ENZO BIOCHEM, INC. PRESS RELEASE DATED FEBRUARY 1, 2024

Exhibit 99.1

 

 

Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments

 

FARMINGDALE, NY, Feb 1, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments.

 

Summary of the Fiscal Year 2023 Annual Shareholder Meeting Proposals

 

Proposal One – The shareholders elected Kara Cannon, Steven J. Pully, Bradley L. Radoff, and Mary Tagliaferri, M.D. to the Company’s Board of Directors to hold office for a term ending as of our Fiscal 2024 annual meeting of shareholders, and until each such director’s successor is elected and qualified.

 

Proposal Two – The shareholders did not approve, by a non-binding advisory vote, the compensation of the Company’s named Executive Officers.

 

Proposal Three – The shareholders ratified the Company’s appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the Company’s fiscal year ending July 31, 2024.

 

Appointment of Kara Cannon as Chief Executive Officer and Patricia Eckert as Chief Financial Officer

 

The Board of Directors resolved unanimously to appoint Kara Cannon and Patricia Eckert on a permanent basis to the roles of Chief Executive Officer and Chief Financial Officer, respectively, removing the “interim” from their titles. “I am very pleased to be working with Kara and Patty, and applaud their dedication and passionate commitment to the Company and their focus on creating shareholder value”, stated Steven Pully, Chairman of the Board of Enzo. “Appointing them to their roles on a permanent basis is recognition of their continuing efforts on behalf of the Company and its shareholders.”

 

About Enzo Biochem

 

Enzo Biochem, a pioneer in molecular diagnostics, contributes to advancing healthcare with its comprehensive portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. A leader in innovation and product development for over 45 years, scientists have trusted Enzo Biochem to manufacture and supply a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins. The Company’s proprietary products and technologies play central roles in all translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. Enzo Biochem, Inc.’s Life Science division supports the work of research centers and industry partners, shaping the future of healthcare worldwide. Enzo Biochem, Inc. has a broad and deep intellectual property portfolio, with patent coverage across many vital enabling technologies. For more information, please visit Enzo.com or follow Enzo Biochem on X and LinkedIn.

 

Forward-Looking Statements

 

Except for historical information, the matters discussed in this release may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including those related to cash flow, gross margins, revenues, and expenses which are dependent on a number of factors outside of the control of the Company including, inter alia, the markets for the Company’s products and services, costs of goods and services, other expenses, government regulations, litigation, and general business conditions. See Risk Factors in the Company’s Form 10-K for the fiscal year ended July 31, 2023. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this release.

 

###

 

Enzo Biochem Contacts    
     
For Enzo Biochem:   For Investors:
Patricia Eckert, CFO   Chris Calabrese
Enzo Biochem   LifeSci Advisors, LLC
631-755-5500   917-680-5608
peckert@enzo.com   ccalabrese@lifesciadvisors.com

  

 GRAPHIC 3 ex99-1_001.jpg GRAPHIC begin 644 ex99-1_001.jpg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end EX-101.SCH 4 enz-20240131.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 enz-20240131_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 enz-20240131_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Jan. 31, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 31, 2024
Entity File Number 001-09974
Entity Registrant Name ENZO BIOCHEM, INC.
Entity Central Index Key 0000316253
Entity Tax Identification Number 13-2866202
Entity Incorporation, State or Country Code NY
Entity Address, Address Line One 81 Executive Blvd. Suite 3
Entity Address, City or Town Farmingdale
Entity Address, State or Province NY
Entity Address, Postal Zip Code 11735
City Area Code 631
Local Phone Number 755-5500
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol ENZ
Security Exchange Name NYSE
Entity Emerging Growth Company false

EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://enzo.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea192624-8k_enzobiochem.htm enz-20240131.xsd enz-20240131_lab.xml enz-20240131_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea192624-8k_enzobiochem.htm": { "nsprefix": "ENZ", "nsuri": "http://enzo.com/20240131", "dts": { "inline": { "local": [ "ea192624-8k_enzobiochem.htm" ] }, "schema": { "local": [ "enz-20240131.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "enz-20240131_lab.xml" ] }, "presentationLink": { "local": [ "enz-20240131_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://enzo.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea192624-8k_enzobiochem.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea192624-8k_enzobiochem.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://enzo.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001213900-24-008745-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-008745-xbrl.zip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end XML 17 ea192624-8k_enzobiochem_htm.xml IDEA: XBRL DOCUMENT 0000316253 2024-01-31 2024-01-31 iso4217:USD shares iso4217:USD shares false 0000316253 8-K 2024-01-31 ENZO BIOCHEM, INC. NY 001-09974 13-2866202 81 Executive Blvd. Suite 3 Farmingdale NY 11735 631 755-5500 false false false false Common Stock, par value $0.01 per share ENZ NYSE false